Chris Guevara is responsible for managing and licensing technologies arising from MGH’s Cancer Center and Molecular Biology department. Prior to joining Innovation in 2023, Chris gained valuable experience as an intern with Mid Atlantic Bio Angels, specializing in Life Science Angel Investments, where he contributed to investment due diligence and managed investor relations. Prior to that, he held the position of a Business Development Fellow at Mount Sinai Innovation Partners, where he triaged inventions, supported the incubator program, conducted marketing, and performed comprehensive competitive landscape analyses.
Chris holds a PhD in Neuroscience from the Icahn School of Medicine at Mount Sinai, a MS in Neuroscience and Education from Columbia University, and a BS in Biology from St. Francis College.